-
公开(公告)号:US20120065266A1
公开(公告)日:2012-03-15
申请号:US13230958
申请日:2011-09-13
申请人: Shinichi Fujita , Yoshiaki Hanzawa , Noriko Yasa , Hiroyuki Matsueda , Hideaki Kihara , Motoyasu Kusano , Osamu Kawamura , Yasuyuki Shimoyama , Hiroko Hosaka , Hiroaki Zai , Atsuto Nagoshi
发明人: Shinichi Fujita , Yoshiaki Hanzawa , Noriko Yasa , Hiroyuki Matsueda , Hideaki Kihara , Motoyasu Kusano , Osamu Kawamura , Yasuyuki Shimoyama , Hiroko Hosaka , Hiroaki Zai , Atsuto Nagoshi
IPC分类号: A61K31/198 , A61P1/00
CPC分类号: A61K9/1652 , A61K31/198 , A61K2300/00
摘要: The present invention provides an oral composition which can more effectively prevent or improve functional gastrointestinal disorders, particularly upper gastrointestinal dysfunction, specifically functional dyspepsia, and is highly safe and suitable for long-term ingestion.The oral composition of the present invention contains sodium glutamate and arginine hydrochloride at a molar ratio of 1:1. The aforementioned composition can be provided as an agent for the prophylaxis or improvement of functional gastrointestinal disorder, and can also be provided in a food or drink.
摘要翻译: 本发明提供一种口服组合物,其可以更有效地预防或改善功能性胃肠道疾病,特别是上消化道功能障碍,特别是功能性消化不良,并且是高度安全的并且适合于长期摄入。 本发明的口服组合物以1:1的摩尔比含有谷氨酸钠和精氨酸盐酸盐。 可以提供上述组合物作为预防或改善功能性胃肠道疾病的药剂,也可以提供在食品或饮料中。